Contracts & Pricing July 19, 2022 Legal Review: Medicare Program, 340B, and State Price Updates 6 Minute Read July's market update is a legislative review of 340B contract pharmacy restrictions, new Medicare bills, and SPTR updates.
Contracts & Pricing June 27, 2022 Pharma vs. 340B 4 Minute Read This month’s market update features the latest news detailing the tumultuous relationship between pharma and 340B, including The Supreme Court, HRSA, and insight on how inflation escalates everything.
Contracts & Pricing June 14, 2022 Top Trends in Contracting 6 Minute Read Using exclusive ICyte Benchmarks from over 230 brands across more than 50 manufacturers, we examine the top trends in specialty pharmacy contracting.
Contracts & Pricing May 22, 2022 CMS Medicaid Copay Ruling 4 Minute Read And other industry updates including the Medi-Cal older adult expansion and profiles of new pharmacy models and 3PLs entering the market.
Contracts & Pricing April 28, 2022 Regulatory Market Updates, April 2022 3 Minute Read We recap pressing issues from the past month, including the DUNS number transition, the latest in the Eli Lilly/Streck case, and rising healthcare spending for U.S. payers.
Contracts & Pricing April 11, 2022 Best Price and Copay Challenges: Frequently Asked Questions 11 Minute Read Common manufacturer concerns on best price calculations, copay accumulators and maximizers, and 340B management as the effective date for the CMS Final Rule approaches.
Contracts & Pricing March 28, 2022 Medicare Part B Sequestration Update 3 Minute Read Regulatory Market Update Updates for Pharma Manufacturers As always, if you have questions on any of the content found in this or previous market updates, please reach out to...
Contracts & Pricing February 24, 2022 Branded Pharma Fee: Manufacturer Considerations 5 Minute Read And other regulatory updates on Line Extension guidance, the upcoming DUNS number transition, and emergency 340B flexibilities.
Contracts & Pricing January 24, 2022 New Year, New Laws: Drug Price Reform, Coverage Gap, and 340B 4 Minute Read Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.
